Publications by authors named "Hannah Gunter"

Claim this Profile
S
Signal Monitoring for Adverse Events Following Immunisation with COVID-19 Vaccines During the SARS-CoV-2 Pandemic: An Evaluation of the South African Surveillance System.
Chenoa Sankar, Stephen Evans, Johanna Catharina Meyer, Hannah May Gunter, Victoria Sekiti

Drug Saf· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic polymorphisms and adverse reactions to antituberculosis therapy.
Hannah M Gunter, Phuti Choshi, Tafadzwa Chimbetete, Sarah Pedretti, Rannakoe J Lehloenya

Pharmacogenomics· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cefepime-induced neurotoxicity.
Jessica Taylor, Hannah M Gunter, Karen Cohen

S Afr J Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empowering African Expertise: Enhancing Safety Data Integration and Signal Detection for COVID-19 Vaccines Through the African Union Smart Safety Surveillance Joint Signal Management Group.
Victoria Prudence Nambasa, Hannah May Gunter, Modupe Bamidele Adeyemo, Neetesh Yanish Bhawaneedin, Marc Blockman

Drug Saf· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine safety surveillance in South Africa through COVID-19: A journey to systems strengthening.
Chenoa Sankar, Johanna C Meyer, Marione Schönfeldt, Hannah Gunter, Halima Dawood

Vaccine· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of drug-induced liver injury in people with HIV treated for tuberculosis: 2024 update.
Tom Boyles, Rebecca H Berhanu, Neliswa Gogela, Hannah Gunter, Tamsin Lovelock

South Afr J HIV Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of serum microRNA-122 in a randomized controlled trial of N-acetylcysteine for treatment of antituberculosis drug-induced liver injury.
Muhammed Shiraz Moosa, Giusy Russomanno, Jeffrey R Dorfman, Hannah Gunter, Chandni Patel

Br J Clin Pharmacol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rechallenge after anti-tuberculosis drug-induced liver injury in a high HIV prevalence cohort.
Muhammed Shiraz Moosa, Gary Maartens, Hannah Gunter, Shaazia Allie, Mohamed F Chughlay

South Afr J HIV Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Controlled Trial of Intravenous N-Acetylcysteine in the Management of Anti-tuberculosis Drug-Induced Liver Injury.
Muhammed Shiraz Moosa, Gary Maartens, Hannah Gunter, Shaazia Allie, Mohamed F Chughlay

Clin Infect Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult medical emergency unit presentations due to adverse drug reactions in a setting of high HIV prevalence.
Johannes P Mouton, Nicole Jobanputra, Christine Njuguna, Hannah Gunter, Annemie Stewart

Afr J Emerg Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis